|
Post by kbrion77 on Jun 23, 2016 9:33:01 GMT -5
How might it be used? On posters perhaps displayed in endo/doctor's offices (is that permitted or commonly practiced)? Elsewhere? Just trying to imagine where we might see it as I believe television advertising is not in the near term plans. I know everyone even Mannkind management has said focus is DTC but it will be interesting to see how quick they go the commercial avenue. Here is an article and quote from Precision Effect: “I strongly believe that if I hadn’t seen TV ads about chronic hepatitis C and new drugs to treat it, I wouldn’t have done anything to protect myself against it. Those commercials raised my awareness of the disease and gave me the courage to try again to beat it. I’m sure I’m not the only person they have helped.”www.precisioneffect.com/2016/06/16/to-dtc-or-not-dtc-what-do-patients-see-on-tv/
|
|
|
Post by thekindaguyiyam on Jun 23, 2016 10:00:07 GMT -5
|
|
|
Post by typeonedad on Jun 23, 2016 11:11:34 GMT -5
I'd like to see a "short tail" on this crazy mascot. This would be lost on the general public but not seasoned type 1's.
|
|
|
Post by rockstarrick on Jun 23, 2016 12:07:28 GMT -5
Based on tweets today from Mike Castagna, it looks like MannKind will be using OUTsulin as a marketing tool. I'm trying to figure out if I like it or not. What is exciting about this, is the fact that Mike C. is confident that he has enough scientific basis to proclaim the speed of Afrezza leaving the body (less chance of hypoglycemia) to not get sideways with the FDA. I think that is great. Because less chance of hypoglycemia is a very important factor for both insurers and diabetics. Actually I think it's brilliant !!! with the JDRF alliance, and now the OUTsulin man, Big Mike and team may be setting the stage to eventually target the pediatric clientale. it will be interesting to watch this unfold over the next 6 months. good luck everybody
|
|
|
Post by babaoriley on Jun 23, 2016 12:26:35 GMT -5
I've owned the company that developed Colo Guard (and watched it plummet from some decent highs), so I'm biased, however, I think that ad is excellent, especially when someone really doesn't care for the idea of having a colonoscopy. If these folks can come up with ads as good for Afrezza, I think it will really help our marketing. The Outsulin character just has to explain to the insulin character why Outsulin is superior, without insulting insulin and without giving the impression to people that Outsulin is not insulin, but some bio-engineered synthetic that is a mere gimmick. These ad people seem sharp, they ought to be able to do that. Even if I really do not like the name "Outsulin."
By the way, whoever made the comment about the placement of the eye-brows - you're right on the money!
|
|
|
Post by compound26 on Jun 23, 2016 12:50:47 GMT -5
I've owned the company that developed Colo Guard (and watched it plummet from some decent highs), so I'm biased, however, I think that ad is excellent, especially when someone really doesn't care for the idea of having a colonoscopy. If these folks can come up with ads as good for Afrezza, I think it will really help our marketing. The Outsulin character just has to explain to the insulin character why Outsulin is superior, without insulting insulin and without giving the impression to people that Outsulin is not insulin, but some bio-engineered synthetic that is a mere gimmick. These ad people seem sharp, they ought to be able to do that. Even if I really do not like the name "Outsulin." By the way, whoever made the comment about the placement of the eye-brows - you're right on the money! babaoriley great points above. Personally I have no opinion as to whether Outsulin is a good or bad brand name. By using a new brand, Mannkind and their Ad agency probably want to start from a clean slate (i.e., wiping out any stains left by Sanofi in their botched launch) and create some excitement and energy for the relaunch and Mannkind 2.0. The brand name itself also seems to be an indirect way to separate Afrezza from the RAAs and create a new product category (ultra-fast insulin) for Afrezza. That seems to be a well-though-out approach. Hope they can generate some buzz and real interest. I really like the Outsulin mascot.
|
|
|
Post by thekindaguyiyam on Jun 23, 2016 12:56:40 GMT -5
I've owned the company that developed Colo Guard (and watched it plummet from some decent highs), so I'm biased, however, I think that ad is excellent, especially when someone really doesn't care for the idea of having a colonoscopy. If these folks can come up with ads as good for Afrezza, I think it will really help our marketing. The Outsulin character just has to explain to the insulin character why Outsulin is superior, without insulting insulin and without giving the impression to people that Outsulin is not insulin, but some bio-engineered synthetic that is a mere gimmick. These ad people seem sharp, they ought to be able to do that. Even if I really do not like the name "Outsulin." By the way, whoever made the comment about the placement of the eye-brows - you're right on the money! Glad to hear the background of those behind the thought. What you describe makes sense; but who is the market of that illustration. I like the concept but don't like the character illustrated. Too cute for me, and I'm not attached to it having to change. Whatever works as what makes people receptive is highly subjective. I'm just trying to figure out who the target market is for that drawing. In one of the last episodes of Silicon Valley something similar is employed; a similar animated character who explains the concept of their company's service: compression. The developers of the Compression App wondered too if the character presented to them was the right one to represent their company. Branding is forever. And on the zen side. It is what it is and any movement to explain and educate I welcome.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 23, 2016 13:02:00 GMT -5
I've owned the company that developed Colo Guard (and watched it plummet from some decent highs), so I'm biased, however, I think that ad is excellent, especially when someone really doesn't care for the idea of having a colonoscopy. If these folks can come up with ads as good for Afrezza, I think it will really help our marketing. The Outsulin character just has to explain to the insulin character why Outsulin is superior, without insulting insulin and without giving the impression to people that Outsulin is not insulin, but some bio-engineered synthetic that is a mere gimmick. These ad people seem sharp, they ought to be able to do that. Even if I really do not like the name "Outsulin." By the way, whoever made the comment about the placement of the eye-brows - you're right on the money! Glad to hear the background of those behind the thought. What you describe makes sense; but who is the market of that illustration. I like the concept but don't like the character illustrated. Too cute for me, and I'm not attached to it having to change. Whatever works as what makes people receptive is highly subjective. I'm just trying to figure out who the target market is for that drawing. In one of the last episodes of Silicon Valley something similar is employed; a similar animated character who explains the concept of their company's service: compression. The developers of the Compression App wondered too if the character presented to them was the right one to represent their company. Branding is forever. And on the zen side. It is what it is and any movement to explain and educate I welcome. target audience could be HCP's telling them Afrezza is out of the body sooner - as almost all doctors know hypos is the one reason they are very conservative with injectables
|
|
|
Post by brotherm1 on Jun 23, 2016 13:26:14 GMT -5
I think Outsulin could use a brother "Quicksulin". Anyone here communicate with Mike that could pass on the thought? I'd hate to see another insulin company trademark and use the word for their own insulin advertising.
|
|
|
Post by mnholdem on Jun 23, 2016 13:29:35 GMT -5
There's more to this:
Take a look at PrecisionEffect's example of what they label as a Head turning brand launch, which includes:
- Web Page design
- Launch advertisement
- App-driven sales support
- Direct-to-patient promotions
...all of which are digitally marketed (internet, including mobile device formatting). Digital web commercials can be easily aired on TV/Cable at a later date but, for now, digital advertising is cheaper than TV and can reach millions of patients and their physicians.
Source: www.precisioneffect.com/portfolio-item/oncology-product-launch/
Check out one of their website designs at Iclusig: www.iclusig.com/ (Note: you can select either a Patient or HCP website.)
---
I anticipate that the new digital Mascot will be used for informing & educating both Patients and Health Care Professionals on initial titration and dosing on a totally NEW Afrezza website, and that Mike Castagna will dump that pitfully lame effort put forth by the ad agency hired by Sanofi for marketing Afrezza, putting that "Surprise! It's Insulin!" image in the rear-view mirror, IMHO.
|
|
|
Post by babaoriley on Jun 23, 2016 14:13:34 GMT -5
I'd like them to be able to say, "It's Insulin, Only Better."
|
|
|
Post by dictatorsaurus on Jun 23, 2016 14:19:57 GMT -5
The Afrezza team:
|
|
|
Post by thekindaguyiyam on Jun 23, 2016 14:23:06 GMT -5
I wonder if management did a market survey first before going whole hog. It reminds me of japanese annimation for little girls. No offense Rick.
|
|
|
Post by mnholdem on Jun 23, 2016 14:24:53 GMT -5
Take a look at PrecisionEffect's example of what they label as a Head turning brand launch, which includes:
- Web Page design
- Launch advertisement
- App-driven sales support
- Direct-to-patient promotions
...all of which are digitally marketed (internet, including mobile device formatting). Digital web commercials can be easily aired on TV/Cable at a later date but, for now, digital advertising is cheaper than TV and can reach millions of patients and their physicians.
|
|
|
Post by sla55 on Jun 23, 2016 14:28:49 GMT -5
Is it Adam Lasher I see in the back?
|
|